Caregiver burden in schizophrenia following paliperidone palmitate long acting injectables treatment: pooled analysis of two double-blind randomized phase three studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2334-265X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Caregiver burden in schizophrenia following paliperidone palmitate long acting injectables treatment: pooled analysis of two double-blind randomized phase three studies ; volume:3 ; number:1 ; day:27 ; month:7 ; year:2017 ; pages:1-6 ; date:12.2017
npj schizophrenia ; 3, Heft 1 (27.7.2017), 1-6, 12.2017
- Creator
-
Gopal, Srihari
Xu, Haiyan
McQuarrie, Kelly
Savitz, Adam
Nuamah, Isaac
Woodruff, Kimberly
Mathews, Maju
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41537-017-0025-5
- URN
-
urn:nbn:de:101:1-2019070721422978975116
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gopal, Srihari
- Xu, Haiyan
- McQuarrie, Kelly
- Savitz, Adam
- Nuamah, Isaac
- Woodruff, Kimberly
- Mathews, Maju
- SpringerLink (Online service)
Other Objects (12)
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial
Reduced crying in term infants fed high beta-palmitate formula: a double-blind randomized clinical trial
High Beta-Palmitate Formula and Bone Strength in Term Infants: A Randomized, Double-Blind, Controlled Trial
Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Upregulated hepatic lipogenesis from dietary sugars in response to low palmitate feeding supplies brain palmitate
Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Racial Differences in Nicotine Reduction: Pooled Results from Two Double-Blind Randomized Controlled Trials
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Family caregiver distress
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial
Reduced crying in term infants fed high beta-palmitate formula: a double-blind randomized clinical trial
High Beta-Palmitate Formula and Bone Strength in Term Infants: A Randomized, Double-Blind, Controlled Trial
Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Upregulated hepatic lipogenesis from dietary sugars in response to low palmitate feeding supplies brain palmitate
Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Racial Differences in Nicotine Reduction: Pooled Results from Two Double-Blind Randomized Controlled Trials
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Family caregiver distress
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial
Reduced crying in term infants fed high beta-palmitate formula: a double-blind randomized clinical trial
High Beta-Palmitate Formula and Bone Strength in Term Infants: A Randomized, Double-Blind, Controlled Trial
Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Upregulated hepatic lipogenesis from dietary sugars in response to low palmitate feeding supplies brain palmitate
Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Racial Differences in Nicotine Reduction: Pooled Results from Two Double-Blind Randomized Controlled Trials
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China